Hepatic Insulin Resistance Is Sufficient to Produce Dyslipidemia and Susceptibility to Atherosclerosis
Sudha B. Biddinger(Boston Children's Hospital), C. Ronald Kahn(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Gregory Stephanopoulos(Massachusetts Institute of Technology), Chhavi Agarwal(Columbia University), Joel T. Haas(Gladstone Institutes), José O. Alemán(Massachusetts Institute of Technology), Ryo Suzuki(Tokyo Medical University), Christian Rask‐Madsen(University of Ulsan), Antonio Hernández‐Ono(Columbia University Irving Medical Center), Erez Scapa(Brigham and Women's Hospital), David E. Cohen(Cornell University), Martin C. Carey(Brigham and Women's Hospital), Henry N. Ginsberg(Columbia University)
Cited by 460
Related Papers
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Triglycerides and Cardiovascular Disease
|Circulation|2011|1.9k
Lipoprotein(a) as a cardiovascular risk factor: current status
|European Heart Journal|2010|1.8k